z-logo
open-access-imgOpen Access
Plasticizer Interaction With the Heart
Author(s) -
Rafael Jaimes,
Damon McCullough,
Bryan Siegel,
Luther Swift,
Daniel McInerney,
James Hiebert,
Erick Andres Perez Alday,
Beatriz Trénor,
Jiansong Sheng,
Javier Sáiz,
Larisa G. Tereshchenko,
Nikki Gillum Posnack
Publication year - 2019
Publication title -
circulation. arrhythmia and electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.684
H-Index - 102
eISSN - 1941-3149
pISSN - 1941-3084
DOI - 10.1161/circep.119.007294
Subject(s) - electrophysiology , medicine , nerve conduction velocity , phthalate , cardiology , repolarization , hyperkalemia , chemistry , anesthesia , organic chemistry
Background: Phthalates are used as plasticizers in the manufacturing of flexible, plastic medical products. Patients can be subjected to high phthalate exposure through contact with plastic medical devices. We aimed to investigate the cardiac safety and biocompatibility of mono-2-ethylhexyl phthalate (MEHP), a phthalate with documented exposure in intensive care patients. Methods: Optical mapping of transmembrane voltage and pacing studies were performed on isolated, Langendorff-perfused rat hearts to assess cardiac electrophysiology after MEHP exposure compared with controls. MEHP dose was chosen based on reported blood concentrations after an exchange transfusion procedure. Results: Thirty-minute exposure to MEHP increased the atrioventricular node (147 versus 107 ms) and ventricular (117 versus 77.5 ms) effective refractory periods, compared with controls. Optical mapping revealed prolonged action potential duration at slower pacing cycle lengths, akin to reverse use dependence. The plateau phase of the action potential duration restitution curve steepened and became monophasic in MEHP-exposed hearts (0.18 versus 0.06 slope). Action potential duration lengthening occurred during late-phase repolarization resulting in triangulation (70.3 versus 56.6 ms). MEHP exposure also slowed epicardial conduction velocity (35 versus 60 cm/s), which may be partly explained by inhibition of Nav 1.5 (874 and 231 µmol/L half-maximal inhibitory concentration, fast and late sodium current).Conclusions: This study highlights the impact of acute MEHP exposure, using a clinically relevant dose, on cardiac electrophysiology in the intact heart. Heightened clinical exposure to plasticized medical products may have cardiac safety implications—given that action potential triangulation and electrical restitution modifications are a risk factor for early after depolarizations and cardiac arrhythmias.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here